| Bringing
university cancer care close to home
Saint Margaret Mercy unveils technologically
advanced cancer-fighting arsenal
For Immediate Release
November 11, 1999
Contact: Maria E. Ramos
(219) 865-2141, ext. 45321
Maria.Ramos@ssfhs.org
Hammond, Ind. -- Saint Margaret Mercy Healthcare Centers
unveiled a $3.4 million technologically advanced cancer-fighting
arsenal for its newly renovated Oncology Center. An advance
preview for the media took place on Nov. 9, followed by
an open house for the general public on Nov. 11.
Special guests Chris and Stefanie Spielman helped kick-off
the open house. Chris, a NFL linebacker, took time off from
his career in 1998 to stand by his wife Stefanie who was
diagnosed with breast cancer. Stefanie's cancer is now in
remission and Chris has retired from the Cleveland Browns.
Saint Margaret Mercy remains at the forefront in the fight
against cancer in Northwest Indiana. And this year is no
exception. "New and exciting renovations and enhancements
made this fall promise even greater advancements in cancer
treatments," said Marla Hoyer-Lareau, administrative
director for The Oncology Center.
The Oncology Center recently replaced some of its equipment
with more sophisticated, cutting-edge, technology-driven
tools. A hi-tech transformation is occurring with the addition
of:
- The Picker ACQSIM CT simulation system. ACQSIM
is the most advanced 3-D computed tomography (CT) simulation
system available. It allows the radiation oncologist to
localize the tumor volume in a matter of minutes. CT images
of parts of the body are subdivided into slices, much
like a loaf of bread, to provide more detailed information
about the organs inside the body.
With the ACQSIM, patient preparation, physical simulation
and data acquisition steps can be completed in less than
30 minutes.
- CT guided prostate seed implants. CT guided
prostate seed implantation is considered by many specialists
in the oncology field to be the next gold standard for
the treatment of patients requiring seed implants. Saint
Margaret Mercy Healthcare Centers is the first hospital
in the Midwest to own the device to facilitate this approach.
CT based prostate seed implantation is extremely accurate
since it allows the radiation oncologist to visualize
in real time exactly where the radioactive seeds are being
placed and to see with high definition the structures
to avoid treating.
Generally, eligible patients have early stage prostate
cancer with a low PSA (prostatic specific antigen) and
a low Gleason Score (its aggressiveness under the microscope).
For those who qualify, this method allows a quick and
easy alternative treatment of prostate cancer in just
one session. The patient avoids a long surgical procedure
with all of its undesirable side effects or two months
of daily radiation treatments.
- The Siemen's Primus multienergy linear accelerator.
The new Siemen's Primus accelerator is the most compact
system with the greatest clearance around patients available
today. This linear accelerator delivers Intensity Modulated
Radiation Therapy (IMRT), an advanced cancer treatment
that allows the delivery of complex doses of radiation
to tumors -- including tumors near vital organs or other
sensitive areas -- while minimizing radiation on healthy
tissue.
In addition, a 3-D Multileaf Collimator (3-D MLC) configures
varying high-dose rates.
- Linac based stereotactic radiosurgery. Radionics
stereotactic hard and software allow the oncologist to
treat a lesion in the brain with the same accuracy as
conventional surgery, without having to make an incision
into the skull. It is an alternative for patients who
have failed conventional radiation therapy and for patients
who are not surgical candidates.
An attachment is made to the linear accelerator and a
frame placed on the patient's skull for scanning with
the CT scanner. The radiation oncologist identifies the
tumor volume to be radiated and prescribes the dose. The
physicist develops the best plan and applies stereotactic
hardware to direct the beam from the linear accelerator
for accurate results.
How we started
The Oncology Center opened its doors in the fall of 1986
with a multienergy linear accelerator and a simulator. In
1987, a second single-energy accelerator was added. Through
the years, major investments to the Oncology Center have
included:
- The introduction of high dose rate afterloading for
brachytherapy
- 3-Dimensional conformal treatment planning
- Department computerization
In 1992, Saint Margaret Mercy was the first hospital in
Northwest Indiana to be a Beta Test site for 3-dimensional
treatment planning system. The center actively participates
in research in the field of oncology. Data from the center
has been used in numerous scientific studies and has appeared
in journals.
"More than 5,000 patients have been seen and treated
at the Oncology Center since its opening," Hoyer-Lareau
said. "The center averages 350 new patients annually
with common diagnoses in breast, prostate, lung and colorectal
cancers."
|